-
Company Insights
Innovation and Patenting activity of Establishment Labs Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Establishment Labs Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewBreast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Breast Implants Pipeline Market Report Overview Breast Implants are also known as intensive-care ventilators. They provide artificial respiratory support to critical patients in ICUs. The Breast Implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments...
-
Sector Analysis
NewNorth Macedonia Beverages Consumption Trends and Forecasts Tracker, Q4 2023
North Macedonia Beverages Market Report Overview The North Macedonia beverages market size was 205.6 million liters (ML) in Q4 2023. The North Macedonia beverages market research report offers comprehensive consumption volume data across several beverage categories for Q4 2023. Furthermore, the report precisely lists new product launches and highlights the latest beverage industry performance and developments every quarter. The North Macedonia beverages market outlook also identifies drivers influencing the segmental growth. For instance, a strong increase in tourist arrivals improved...
-
Product Insights
NewLikelihood of Approval Analysis for Herpesviridae Infections
Overview How likely is it that the drugs in Herpesviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Herpesviridae Infections Overview The infections caused by Herpesviridae viruses are called Herpesviridae...
-
Sector Analysis
NewFinland Cards and Payments – Opportunities and Risks to 2028
Finland Cards and Payments Market Report Overview The annual value of card transactions in the Finland cards and payments market was $72.9 billion in 2023. The value is expected to grow at a CAGR of more than 4% during 2024-2028. Finland has a matured digital payments market facilitated by widespread familiarity with electronic payments, a highly banked population, and a well-established payment infrastructure. Finland Card Transactions Outlook, 2024-2028 ($ Billion) Buy the Full Report for More Information on the Finland...
-
Sector Analysis
NewASEAN Destination Tourism Trends Insight by Type, Source Markets, Foreign Direct Investment and Future Opportunities, 2024 Update
ASEAN Destination Tourism Report Overview The Association of Southeast Asian Nations (ASEAN) consists of Brunei Darussalam, Burma, Cambodia, Indonesia, Laos, Malaysia, Philippines, Singapore, Thailand, and Vietnam. Tourism is one of the key areas of ASEAN's cooperation. Therefore, they established the ASEAN Tourism Forum (ATF) in 1981. The ATF is a cooperative regional effort to promote the ASEAN as one tourist destination. The ASEAN destination tourism market research report provides an in-depth analysis of destination markets, infrastructure developments, and attractions. The...
-
Product Insights
NewLikelihood of Approval Analysis for Retroviridae Infections
Overview How likely is it that the drugs in Retroviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retroviridae Infections Overview Retroviruses belong to a family of enveloped RNA viruses...
-
Product Insights
NewLikelihood of Approval Analysis for Simplexvirus (HSV) Infections
Overview How likely is it that the drugs in Simplexvirus (HSV) Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Simplexvirus (HSV) Infections Overview Herpes simplex virus (HSV) infections, also known...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Liraglutide in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Liraglutide in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liraglutide in Parkinson's Disease Drug Details: Liraglutide (Victoza) is a potent anti-diabetic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Liraglutide in Pouchitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Liraglutide in Pouchitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liraglutide in Pouchitis Drug Details: Liraglutide (Victoza) is a potent anti-diabetic agent. It...